Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidia Ruiz

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 26, 2013
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failureRaphael Z Sangeda, Kristof Theys, Gertjan Beheydt, et al.
Scientific Reports|January 29, 2021
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severityBenjamin Trinité, Ferran Tarrés-Freixas, Jordi Rodon, et al.
Biomedicines|March 25, 2022
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease SeverityLuis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
The Journal of Infectious Diseases|October 20, 2009
Transmission of drug-resistant HIV-1 is stabilizing in EuropeJurgen Vercauteren, Annemarie M J Wensing, David A M C van de Vijver, et al.
Retrovirology|October 4, 2012
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patientsKristof Theys, Koen Deforche, Jurgen Vercauteren, et al.
Diabetes Technology & Therapeutics|July 29, 2025
Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential StudyPedro Pujante Alarcón, Elías Delgado Álvarez, Carmen Lambert Goitia, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2026
The recent introduction of mosaic mtr-carrying Neisseria gonorrhoeae lineages boosts local transmissionAndrea Sánchez-Serrano, Carlos Francés-Cuesta, Nuria Jiménez-Hernández, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 3, 2021
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involvedLuis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
The New England Journal of Medicine|December 8, 2020
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19Oriol Mitjà, Marc Corbacho-Monné, Maria Ubals, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2006
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypesDavid A van de Vijver, Annemarie M J Wensing, Gioacchino Angarano, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 26, 2013
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failureRaphael Z Sangeda, Kristof Theys, Gertjan Beheydt, et al.
Scientific Reports|January 29, 2021
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severityBenjamin Trinité, Ferran Tarrés-Freixas, Jordi Rodon, et al.
Biomedicines|March 25, 2022
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease SeverityLuis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
The Journal of Infectious Diseases|October 20, 2009
Transmission of drug-resistant HIV-1 is stabilizing in EuropeJurgen Vercauteren, Annemarie M J Wensing, David A M C van de Vijver, et al.
Retrovirology|October 4, 2012
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patientsKristof Theys, Koen Deforche, Jurgen Vercauteren, et al.
Diabetes Technology & Therapeutics|July 29, 2025
Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential StudyPedro Pujante Alarcón, Elías Delgado Álvarez, Carmen Lambert Goitia, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2026
The recent introduction of mosaic mtr-carrying Neisseria gonorrhoeae lineages boosts local transmissionAndrea Sánchez-Serrano, Carlos Francés-Cuesta, Nuria Jiménez-Hernández, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 3, 2021
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involvedLuis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
The New England Journal of Medicine|December 8, 2020
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19Oriol Mitjà, Marc Corbacho-Monné, Maria Ubals, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2006
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypesDavid A van de Vijver, Annemarie M J Wensing, Gioacchino Angarano, et al.
Pageof 17